| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Former Director | Stock Options | 76,106 | $197,876 | $2.60 | 10 Jun 2021 | Direct |
| OKYO Pharma Ltd | Chief Executive Officer, Director | American Depositary Shares | 12,500 | $50,000 | $4.00 | 19 May 2022 | Direct |
| Hepion Pharmaceuticals, Inc. | Director | Stock Options | 102,120 | 19 Feb 2024 | Direct | ||
| Virpax Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 12,091 | 01 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals, Inc. | 19 Feb 2024 | 1 | $0 | 4 | Director | 21 Feb 2024, 20:01 |
| OKYO | OKYO Pharma Ltd | 19 May 2022 | 1 | +$50,000 | 4 | Chief Executive Officer, Director | 19 May 2022, 11:14 |
| OKYO | OKYO Pharma Ltd | 16 May 2022 | 0 | $0 | 3 | Chief Executive Officer, Director | 16 May 2022, 17:44 |
| VRPX | Virpax Pharmaceuticals, Inc. | 01 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 16:18 |
| CRDF | Cardiff Oncology, Inc. | 10 Jun 2021 | 8 | $0 | 4 | Former Director | 15 Jun 2021, 10:06 |
| HEPA | Hepion Pharmaceuticals, Inc. | 18 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 16:36 |